Damora Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Damora Therapeutics, Inc. has filed 335 SEC EDGAR filings since 16 Jan 2020

SEC filing history

Showing 51-75 of 335 matching filings.

Per page
25
Current page
3
4

4

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39655

DEF 14A

Filing date
31 Dec 2025
Reporting date
09 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-292175

424B3

Filing date
31 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-292175

EFFECT filing

Filing date
23 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-39655

PRE 14A

Filing date
16 Dec 2025
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91812

SCHEDULE 13G filing

Filing date
05 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91812

SCHEDULE 13G filing

Filing date
05 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-564756

D filing

Filing date
21 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
17 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
17 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-91812

SCHEDULE 13D filing

Filing date
17 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
17 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91812

SCHEDULE 13G filing

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91812

SCHEDULE 13D/A filing

Filing date
09 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91812

SCHEDULE 13D/A filing

Filing date
25 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jul 2025
Reporting date
03 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .